3-iodobenzylguanidine has been researched along with Genetic Predisposition in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (37.50) | 29.6817 |
2010's | 4 (50.00) | 24.3611 |
2020's | 1 (12.50) | 2.80 |
Authors | Studies |
---|---|
Bardai, A; Blom, MT; Karemaker, JM; Tan, HL; Verberne, HJ | 1 |
Almeida, AG; Bordalo e Sá, A; Cantinho, G; Conceição, I; Cortez-Dias, N; Coutinho, MC; de Carvalho, M; Diogo, AN; Gonçalves, S; Oliveira, A | 1 |
Barone, P; Cuocolo, A; De Michele, G; De Rosa, A; Pappatà, S; Pellecchia, MT; Pellegrino, T; Peluso, S; Saccà, F | 1 |
Hasegawa, K; Kowa, H; Stoessl, AJ; Wszolek, ZK; Yagishita, S; Yokoyama, T | 1 |
Alzualde, A; Bergareche, A; Gorostidi, A; Goyenechea, E; López de Munain, A; Martí Massó, JF; Moreno, F; Poza, JJ; Rodríguez, F; Ruiz-Martínez, J | 1 |
Giubellino, A; Pacak, K; Shah, U | 1 |
Kjaer, A; Petersen, CL | 1 |
Clark, OH; Duh, QY; Kebebew, E; Zarnegar, R | 1 |
2 review(s) available for 3-iodobenzylguanidine and Genetic Predisposition
Article | Year |
---|---|
Pheochromocytoma: implications in tumorigenesis and the actual management.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adrenalectomy; Antineoplastic Agents; Catecholamines; Cell Hypoxia; Combined Modality Therapy; Diagnosis, Differential; Disease Management; Embolization, Therapeutic; Genes, Neurofibromatosis 1; Genetic Predisposition to Disease; Humans; Hypertension; Iodine Radioisotopes; Mutation; Neoplasm Proteins; Neoplastic Syndromes, Hereditary; Pheochromocytoma; Prognosis; Proto-Oncogene Proteins c-ret; Succinate Dehydrogenase; Von Hippel-Lindau Tumor Suppressor Protein | 2012 |
Malignant pheochromocytoma.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adrenalectomy; Genetic Predisposition to Disease; Humans; Laparoscopy; Liver Neoplasms; Pheochromocytoma; Radiopharmaceuticals; Tomography, X-Ray Computed | 2006 |
6 other study(ies) available for 3-iodobenzylguanidine and Genetic Predisposition
Article | Year |
---|---|
An inherited sudden cardiac arrest syndrome may be based on primary myocardial and autonomic nervous system abnormalities.
Topics: 3-Iodobenzylguanidine; Adult; Autonomic Nervous System; Baroreflex; Death, Sudden, Cardiac; Female; Genetic Predisposition to Disease; Haplotypes; Heart Defects, Congenital; Heart Rate; Humans; Male; Middle Aged; Nervous System Malformations; Radionuclide Imaging; Syndrome; Ventricular Fibrillation | 2022 |
Reduced myocardial 123-iodine metaiodobenzylguanidine uptake: a prognostic marker in familial amyloid polyneuropathy.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Aged, 80 and over; Amyloid Neuropathies, Familial; Cardiomyopathies; Echocardiography; Electrocardiography, Ambulatory; Female; Genetic Predisposition to Disease; Heart; Humans; Kaplan-Meier Estimate; Liver Transplantation; Longitudinal Studies; Male; Middle Aged; Multivariate Analysis; Mutation; Phenotype; Prealbumin; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Risk Factors; Sympathetic Nervous System; Time Factors; Young Adult | 2013 |
Myocardial
Topics: 3-Iodobenzylguanidine; Adult; Aged; Autonomic Nervous System Diseases; Female; Genetic Predisposition to Disease; Heart; Humans; Male; Middle Aged; Mutation; Parkinson Disease; Polymorphism, Single Nucleotide; Radionuclide Imaging; Radiopharmaceuticals; Ubiquitin-Protein Ligases | 2017 |
Familial parkinsonism: study of original Sagamihara PARK8 (I2020T) kindred with variable clinicopathologic outcomes.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Aged, 80 and over; DNA Mutational Analysis; Family Health; Female; Gene Frequency; Genetic Predisposition to Disease; Genotype; Humans; Isoleucine; Japan; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; Male; Middle Aged; Mutation; Parkinsonian Disorders; Positron-Emission Tomography; Protein Serine-Threonine Kinases; Radiopharmaceuticals; Tetrabenazine; Tyrosine | 2009 |
Olfactory deficits and cardiac 123I-MIBG in Parkinson's disease related to the LRRK2 R1441G and G2019S mutations.
Topics: 3-Iodobenzylguanidine; Aged; Cohort Studies; DNA Mutational Analysis; Female; Genetic Predisposition to Disease; Heart; Humans; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; Male; Middle Aged; Mutation; Myocardial Perfusion Imaging; Olfaction Disorders; Parkinson Disease; Protein Serine-Threonine Kinases; Radiopharmaceuticals; Taste | 2011 |
Primary diagnosis of multiple pheochromocytomas in the brother of a MEN-2 patient by simultaneous MIBG scintigraphy and low-dose computed tomography.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Aged; Female; Genetic Predisposition to Disease; Genetic Testing; Humans; Liver Neoplasms; Male; Multiple Endocrine Neoplasia Type 2a; Pheochromocytoma; Radionuclide Imaging; Siblings; Tomography, X-Ray Computed | 2002 |